Primary Care Research Group, School of Pharmacy, Medical Biology Centre, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
Int J Clin Pharm. 2021 Feb;43(1):275-279. doi: 10.1007/s11096-020-01116-y. Epub 2020 Aug 16.
COVID-19 has changed life beyond recognition for millions of individuals, as countries implement social distancing measures to prevent disease transmission. For certain patient groups, such as community-dwelling older people with dementia (PwD), these restrictions may have far-reaching consequences. Medicines management may be adversely affected and deserves careful thought. PwD face unique challenges with medicines management compared to other older people, often relying upon support from family/carers and primary healthcare professionals. This article considers potential issues that PwD may face with each component of medicines management (prescribing, dispensing, administration, adherence, review), and based on previous research, highlights strategies to support PwD and their carers during this time. Primary healthcare professionals must be attentive to medicines-related needs of community-dwelling PwD, particularly those living alone, both during the pandemic and as restrictions are lifted. Carers of PwD continue to have a critical role to play in medicines management, and also require support.
新冠疫情使数百万人的生活发生了翻天覆地的变化，各国纷纷实施社交隔离措施以防止疾病传播。对于某些特定患者群体，如居住在社区的痴呆症老年人（PwD），这些限制可能会产生深远的影响。药品管理可能会受到不利影响，因此值得认真考虑。与其他老年人相比，PwD 在药品管理方面面临着独特的挑战，他们通常依赖于家人/护理者和初级保健专业人员的支持。本文考虑了 PwD 在药品管理的每个环节（处方、配药、给药、用药依从性、审查）可能面临的潜在问题，并根据以往的研究，强调了在这一时期支持 PwD 及其护理者的策略。初级保健专业人员必须关注居住在社区的 PwD 的药品相关需求，尤其是那些独居的患者，不仅在大流行期间，而且在限制解除后也是如此。PwD 的护理者在药品管理方面继续发挥着关键作用，他们也需要得到支持。
